Last updated: December 3, 2024
Sponsor: Mayo Clinic
Overall Status: Active - Recruiting
Phase
N/A
Condition
Neoplasms
Treatment
Electronic Health Record Review
Biospecimen Collection
Clinical Study ID
NCT05112614
19-003060
NCI-2021-10793
Ages 18-99 All Genders
Study Summary
Eligibility Criteria
Inclusion
Inclusion Criteria:
Age 18-99
Diagnosis of cancer and undergoing cancer therapy or scheduled to start cancertherapy or undergoing stem cell transplant for any hematological condition
Exclusion
Exclusion Criteria:
Unable to provide informed consent
Vulnerable adults
Study Design
Total Participants: 5000
Treatment Group(s): 2
Primary Treatment: Electronic Health Record Review
Phase:
Study Start date:
September 11, 2019
Estimated Completion Date:
October 01, 2030
Study Description
Connect with a study center
Mayo Clinic in Arizona
Scottsdale, Arizona 85259
United StatesSite Not Available
Mayo Clinic in Florida
Jacksonville, Florida 32224
United StatesSite Not Available
Mayo Clinic in Rochester
Rochester, Minnesota 55905
United StatesActive - Recruiting
Not the study for you?
Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.